Pacific Neuroscience Institute

The Pacific Treatment & Research in Psychedelics (TRIP) Program is dedicated to the development of psychedelic-assisted therapies and the scientific exploration of how altered states of consciousness can be harnessed to change behaviour and improve brain health and quality of life.

Pacific Neuroscience Institute

Led by Dr Keith Heinzerling, the TRIP program is exploring the use of psilocybin in the treatment of major depressive disorder and alcohol use disorder in two separate clinical trials. Located in Santa Monica, California, TRIP also offers ketamine-assisted therapy for a range of mental disorders.

Company Information

Pacific Neuroscience Institute Website

August, 2019


B2C Research Institute Clinic

Compounds of Interest

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office Santa Monica, CA, USA